Literature DB >> 25200868

Human small intestinal epithelial cells differentiated from adult intestinal stem cells as a novel system for predicting oral drug absorption in humans.

Toru Takenaka1, Naomoto Harada1, Jiro Kuze1, Masato Chiba1, Takahiro Iwao1, Tamihide Matsunaga2.   

Abstract

Adult intestinal stem cells (ISCs) possess both a long-term proliferation ability and differentiation capability into enterocytes. As a novel in vitro system for the evaluation of drug absorption, we characterized a human small intestinal epithelial cell (HIEC) monolayer that differentiated from adult ISCs. Continuous proliferation/differentiation from ISCs consistently conferred the capability of maturation of enterocytes to HIECs over 25 passages. The morphologically matured HIEC monolayer consisted of polarized columnar epithelia with dense microvilli, tight junctions, and desmosomes 8 days after seeding onto culture inserts. Transepithelial electrical resistance across the monolayer was 9-fold lower in HIECs (98.9 Ω × cm(2)) than in Caco-2 cells (900 Ω × cm(2)), which indicated that the looseness of the tight junctions in the HIEC monolayer was similar to that in the human small intestine (approximately 40 Ω × cm(2)). No significant differences were observed in the overall gene expression patterns of the major drug-metabolizing enzymes and transporters between the HIEC and Caco-2 cell monolayers. Furthermore, the functions of P-glycoprotein and breast cancer resistance protein in the HIEC monolayer were confirmed by the vectorial transport of marker substrates and their disappearance in the presence of specific inhibitors. The apparent drug permeability values of paracellularly transported compounds (fluorescein isothiocyanate-dextran 4000, atenolol, and terbutaline) and nucleoside transporter substrates (didanosine, ribavirin, and doxifluridine) in the HIEC monolayer were markedly higher than those of Caco-2 cells, whereas transcellularly transported drugs (pindolol and midazolam) were equally well permeated. In conclusion, the HIEC monolayer can serve as a novel and superior alternative to the conventional Caco-2 cell monolayer for predicting oral absorption in humans.
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25200868     DOI: 10.1124/dmd.114.059493

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  14 in total

1.  Generation of Caco-2 cells stably expressing CYP3A4·POR·UGT1A1 and CYP3A4·POR·UGT1A1*6 using a PITCh system.

Authors:  Ryosuke Negoro; Naoki Yamada; Keita Watanabe; Yusuke Kono; Takuya Fujita
Journal:  Arch Toxicol       Date:  2021-10-16       Impact factor: 5.153

2.  Functional Comparison of Human Colonic Carcinoma Cell Lines and Primary Small Intestinal Epithelial Cells for Investigations of Intestinal Drug Permeability and First-Pass Metabolism.

Authors:  Yoshiyuki Yamaura; Brian D Chapron; Zhican Wang; Jonathan Himmelfarb; Kenneth E Thummel
Journal:  Drug Metab Dispos       Date:  2015-12-23       Impact factor: 3.922

3.  Robotically handled whole-tissue culture system for the screening of oral drug formulations.

Authors:  Thomas von Erlach; Sarah Saxton; Yunhua Shi; Daniel Minahan; Daniel Reker; Farhad Javid; Young-Ah Lucy Lee; Carl Schoellhammer; Tina Esfandiary; Cody Cleveland; Lucas Booth; Jiaqi Lin; Hannah Levy; Sophie Blackburn; Alison Hayward; Robert Langer; Giovanni Traverso
Journal:  Nat Biomed Eng       Date:  2020-04-27       Impact factor: 25.671

4.  Combined Effects of Lipophilic Phycotoxins (Okadaic Acid, Azapsiracid-1 and Yessotoxin) on Human Intestinal Cells Models.

Authors:  Pierre-Jean Ferron; Kevin Dumazeau; Jean-François Beaulieu; Ludovic Le Hégarat; Valérie Fessard
Journal:  Toxins (Basel)       Date:  2016-02-19       Impact factor: 4.546

5.  Bioprinted 3D Primary Human Intestinal Tissues Model Aspects of Native Physiology and ADME/Tox Functions.

Authors:  Lauran R Madden; Theresa V Nguyen; Salvador Garcia-Mojica; Vishal Shah; Alex V Le; Andrea Peier; Richard Visconti; Eric M Parker; Sharon C Presnell; Deborah G Nguyen; Kelsey N Retting
Journal:  iScience       Date:  2018-03-27

6.  Guidance on safety evaluation of sources of nutrients and bioavailability of nutrient from the sources.

Authors:  Maged Younes; Peter Aggett; Fernando Aguilar; Riccardo Crebelli; Birgit Dusemund; Metka Filipicč; Maria Jose Frutos; Pierre Galtier; Ursula Gundert-Remy; Gunter Georg Kuhnle; Claude Lambré; Jean-Charles Leblanc; Inger Therese Lillegaard; Peter Moldeus; Alicja Mortensen; Agneta Oskarsson; Ivan Stankovic; Ine Waalkens-Berendsen; Rudolf Antonius Woutersen; Matthew Wright; Alessandro Di Domenico; Susan Fairweather-Tait; Harry McArdle; Camilla Smeraldi; David Gott
Journal:  EFSA J       Date:  2018-06-26

Review 7.  Human small intestinal organotypic culture model for drug permeation, inflammation, and toxicity assays.

Authors:  Jan Markus; Tim Landry; Zachary Stevens; Hailey Scott; Pierre Llanos; Michelle Debatis; Alexander Armento; Mitchell Klausner; Seyoum Ayehunie
Journal:  In Vitro Cell Dev Biol Anim       Date:  2020-11-25       Impact factor: 2.416

8.  Generation of Human-Induced Pluripotent Stem Cell-Derived Functional Enterocyte-Like Cells for Pharmacokinetic Studies.

Authors:  Shinpei Yoshida; Takayuki Honjo; Keita Iino; Ryunosuke Ishibe; Sylvia Leo; Tomoka Shimada; Teruhiko Watanabe; Masaya Ishikawa; Kazuya Maeda; Hiroyuki Kusuhara; Nobuaki Shiraki; Shoen Kume
Journal:  Stem Cell Reports       Date:  2021-01-28       Impact factor: 7.765

9.  Functional Enterospheres Derived In Vitro from Human Pluripotent Stem Cells.

Authors:  Rohan R Nadkarni; Soumeya Abed; Brian J Cox; Sonam Bhatia; Jennifer T Lau; Michael G Surette; Jonathan S Draper
Journal:  Stem Cell Reports       Date:  2017-08-31       Impact factor: 7.765

10.  Direct On-Chip Differentiation of Intestinal Tubules from Induced Pluripotent Stem Cells.

Authors:  Elena Naumovska; Germaine Aalderink; Christian Wong Valencia; Kinga Kosim; Arnaud Nicolas; Stephen Brown; Paul Vulto; Kai S Erdmann; Dorota Kurek
Journal:  Int J Mol Sci       Date:  2020-07-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.